www.fdanews.com/articles/126283-oracle-buying-drug-trials-software-maker-for-685-million

Oracle Buying Drug Trials Software Maker for $685 Million

April 16, 2010

Oracle announced plans to buy Phase Forward, which develops software for drug manufacturers, for about US $685 million. The deal is expected to close mid-year.
Computerworld